119 related articles for article (PubMed ID: 6968572)
21. [Anaplastic myeloma and immunoblastic lymphoma: a comparison].
Banks PM; Strand WR; Kyle RA
Verh Dtsch Ges Pathol; 1983; 67():447-50. PubMed ID: 6666273
[No Abstract] [Full Text] [Related]
22. T cell lymphoblastic leukaemia/lymphoma associated with a microenvironment of thymic asteroid B cells in the bone marrow.
Naresh KN; May PC; Reid AG; Marks AJ; Macdonald D; Kanfer E
Histopathology; 2010 Oct; 57(4):549-54. PubMed ID: 20875071
[TBL] [Abstract][Full Text] [Related]
23. Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients.
Gadó K; Nagy G; Hasitz A; Tóth BE; Rimanóczi E; Domján G
Neuroimmunomodulation; 2001; 9(2):95-102. PubMed ID: 11549891
[TBL] [Abstract][Full Text] [Related]
24. In vitro growth of lymphoma colonies from children with non-Hodgkin's lymphoma.
Smith SD; Wood GW; Fried P; Lowman JT
Cancer; 1981 Dec; 48(12):2612-23. PubMed ID: 6975647
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas.
Corradini P; Boccadoro M; Voena C; Pileri A
J Exp Med; 1993 Sep; 178(3):1091-6. PubMed ID: 8350048
[TBL] [Abstract][Full Text] [Related]
26. C-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A
Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
[TBL] [Abstract][Full Text] [Related]
27. Primary bioassay of human myeloma stem cells.
Hamburger A; Salmon SE
J Clin Invest; 1977 Oct; 60(4):846-54. PubMed ID: 302265
[TBL] [Abstract][Full Text] [Related]
28. Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow.
Engels K; Jungnickel B; Tobollik S; Hansmann ML; Kriener S; Willenbrock K
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):521-9. PubMed ID: 18776814
[TBL] [Abstract][Full Text] [Related]
29. EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells.
Müller M; Gounari F; Prifti S; Hacker HJ; Schirrmacher V; Khazaie K
Cancer Res; 1998 Dec; 58(23):5439-46. PubMed ID: 9850077
[TBL] [Abstract][Full Text] [Related]
30. Multidrug resistance of a continuously differentiating monoclonal B lineage in the blood and bone marrow of patients with multiple myeloma.
Pilarski LM; Cass CE; Tsuro T; Belch AR
Curr Top Microbiol Immunol; 1992; 182():177-85. PubMed ID: 1362698
[No Abstract] [Full Text] [Related]
31. Bone marrow kinetic studies on three patients with myelomatosis. Indications for malignant proliferation within both the plasma cell and lymphoid cell compartments.
Mellstedt H; Killander D; Pettersson D
Acta Med Scand; 1977; 202(5):413-7. PubMed ID: 335796
[TBL] [Abstract][Full Text] [Related]
32. Human bone marrow lymphocytes. III. Polyclonal activation of B lymphocytes in human bone marrow measured by a direct plaque-forming cell assay.
Fauci AS; Pratt KR
J Immunol; 1977 Apr; 118(4):1150-3. PubMed ID: 321685
[TBL] [Abstract][Full Text] [Related]
33. The pattern of human lymph node involvement by the non-Hodgkin lymphomas of B-cell lineage.
Syrjänen KJ
Neoplasma; 1979; 26(5):589-96. PubMed ID: 316500
[TBL] [Abstract][Full Text] [Related]
34. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
35. Colony growth and self renewal of plasma cell precursors in multiple myeloma.
Takahashi T; Lim B; Jamal N; Tritchler D; Lockwood G; McKinney S; Bergsagel DE; Messner HA
J Clin Oncol; 1985 Dec; 3(12):1613-23. PubMed ID: 4067612
[TBL] [Abstract][Full Text] [Related]
36. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
37. In vitro growth of human multiple myeloma: implications for biology and therapy.
Caligaris-Cappio F; Gregoretti MG; Ghia P; Bergui L
Hematol Oncol Clin North Am; 1992 Apr; 6(2):257-71. PubMed ID: 1582973
[TBL] [Abstract][Full Text] [Related]
38. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
Rasmussen T; Lodahl M; Hancke S; Johnsen HE
Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
[TBL] [Abstract][Full Text] [Related]
39. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
40. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Agbay RLMC; Loghavi S; Zuo Z; Fayad L; Dabaja B; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2018 Apr; 42(4):492-499. PubMed ID: 29309302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
